ANN TRANSL MED 润色咨询

Annals of Translational Medicine

出版年份:暂无数据 年文章数:748 投稿命中率:57.14%

出版周期:Biweekly 自引率:暂无数据 审稿周期:平均3.09月

前往期刊查询

投稿信息

投稿信息
审稿速度
平均3.09月 (网友贡献,非官方数据)
投稿命中率
57.14% (网友贡献,非官方数据)
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2019年中国人文章占该期刊总数量42.07% (2018年为16.97%)
自引率
暂无数据
年文章数
748
期刊官网
点击查看 (点击次数:2825)
点击查看 (点击次数:1283次)
作者需知
点击查看 (点击次数:310次)
期刊简介
稿件收录要求

The Annals of Translational Medicine (Ann Transl Med; ATM; Print ISSN 2305-5839; Online ISSN 2305-5847) is an international, peer-reviewed Open Access journal featuring original and observational investigations in the broad fields of laboratory, clinical, and public health research, aiming to provide practical up-to-date information in significant research from all subspecialties of medicine and to broaden the readers’ vision and horizon from bench to bed and bed to bench. It is published quarterly (April 2013- Dec. 2013), monthly (Jan. 2014 - Feb. 2015), biweekly (March 2015-) and openly distributed worldwide.

Annals of Translational Medicine is indexed in PubMed in Sept 2014 and in SCIE in 2018 (Impact Factor: 3.689). Specific areas of interest include, but not limited to, multimodality therapy, epidemiology, biomarkers, imaging, biology, pathology, and technical advances related to medicine. Submissions describing preclinical research with potential for application to human disease, and studies describing research obtained from preliminary human experimentation with potential to further the understanding of biological mechanism underlying disease are encouraged. Also warmly welcome are studies describing public health research pertinent to clinic, disease diagnosis and prevention, or healthcare policy.


With a focus on interdisciplinary academic cooperation, ATM aims to expedite the translation of scientific discovery into new or improved standards of management and health outcomes practice.

Submission Turnaround Time:    
  • External peer review: 1-2 months.
  • Acceptance to Publication Ahead of Print: 20 days.
  • Acceptance to Publication: 1-3 months. Original Articles are listed as priority.